Analysis of the RIMDAMAL trial - Authors' reply

Lancet. 2019 Sep 21;394(10203):1006-1007. doi: 10.1016/S0140-6736(19)32139-7.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Humans
  • Ivermectin
  • Malaria*
  • Mass Drug Administration*

Substances

  • Ivermectin